BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15555372)

  • 21. Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population.
    Wang G; Zhang L; Li Q
    Biochem Biophys Res Commun; 2006 Mar; 341(2):310-3. PubMed ID: 16413497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GSTT1 and CYP2E1 polymorphisms and trihalomethanes in drinking water: effect on childhood leukemia.
    Infante-Rivard C; Amre D; Sinnett D
    Environ Health Perspect; 2002 Jun; 110(6):591-3. PubMed ID: 12055050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The GSTM1 and GSTT1 genetic polymorphisms and susceptibility to acute lymphoblastic leukemia in children from north Portugal.
    Alves S; Amorim A; Ferreira F; Norton L; Prata MJ
    Leukemia; 2002 Aug; 16(8):1565-7. PubMed ID: 12145701
    [No Abstract]   [Full Text] [Related]  

  • 24. NQO1, MPO, CYP2E1, GSTT1 and GSTM1 polymorphisms and biological effects of benzene exposure--a literature review.
    Dougherty D; Garte S; Barchowsky A; Zmuda J; Taioli E
    Toxicol Lett; 2008 Nov; 182(1-3):7-17. PubMed ID: 18848868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group.
    Stanulla M; Dynybil C; Bartels DB; Dördelmann M; Löning L; Claviez A; Schrappe M;
    Haematologica; 2007 Nov; 92(11):1581-2. PubMed ID: 18024413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children.
    Silveira Vda S; Canalle R; Scrideli CA; Queiroz RG; Tone LG
    Environ Mol Mutagen; 2010 Jan; 51(1):48-56. PubMed ID: 19593802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of genetic polymorphisms of xenobiotic metabolizing enzymes on the risk of developing leukemia in a Tunisian population.
    Ouerhani S; Nefzi MA; Menif S; Safra I; Douzi K; Fouzai C; Ben Ghorbel G; Ben Bahria I; Ben Ammar Elgaaied A; Abbes S
    Bull Cancer; 2011 Dec; 98(12):95-106. PubMed ID: 22146408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.
    Alexandrie AK; Nyberg F; Warholm M; Rannug A
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):908-14. PubMed ID: 15184245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variants of the cytochrome P450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population.
    Shao J; Gu M; Zhang Z; Xu Z; Hu Q; Qian L
    Int J Urol; 2008 Mar; 15(3):216-21. PubMed ID: 18304215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia.
    Tumer TB; Yilmaz D; Tanrikut C; Sahin G; Ulusoy G; Arinç E
    Leuk Res; 2010 Oct; 34(10):1275-81. PubMed ID: 20394984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk for acute lymphoblastic leukemia in children with cytochrome P450A1 (CYP1A1)- and NAD(P)H:quinone oxidoreductase 1 (NQO1)-inherited gene variants.
    Yamaguti GG; Lourenço GJ; Silveira VS; Tone LG; Lopes LF; Lima CS
    Acta Haematol; 2010; 124(3):182-4. PubMed ID: 20962519
    [No Abstract]   [Full Text] [Related]  

  • 32. [Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia].
    Gra OA; Glotov AS; Kozhekbaeva Zhm; Makarova OV; Nasedkina TV
    Mol Biol (Mosk); 2008; 42(2):214-25. PubMed ID: 18610829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Investigation of GSTT1, GSTM1 and NQO1 genes polymorphisms in myelodysplastic syndromes].
    Yang L; Zou X; Zhang MR; Zhang Y; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):674-7. PubMed ID: 16620556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.
    Bolufer P; Collado M; Barragan E; Calasanz MJ; Colomer D; Tormo M; González M; Brunet S; Batlle M; Cervera J; Sanz MA
    Br J Haematol; 2007 Feb; 136(4):590-6. PubMed ID: 17367411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits.
    Wu SH; Tsai SM; Hou MF; Lin HS; Hou LA; Ma H; Lin JT; Yeh FL; Tsai LY
    Breast Cancer Res Treat; 2006 Nov; 100(1):93-8. PubMed ID: 16758119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excess transmission of the NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in families of children with acute lymphoblastic leukemia.
    Infante-Rivard C; Vermunt JK; Weinberg CR
    Am J Epidemiol; 2007 Jun; 165(11):1248-54. PubMed ID: 17332311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on polymorphisms in metabolic enzyme genes, DNA repair genes and individual susceptibility to childhood leukemia].
    Zhu R; Xia Z
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):635-8. PubMed ID: 15612500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
    Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
    Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
    Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
    Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck.
    Li G; Liu Z; Sturgis EM; Chamberlain RM; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1034-6. PubMed ID: 15824189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.